BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today reported financial results for the third quarter ended September 30, 2023, and provided recent business updates. “The third quarter of…Read More
Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
